AYTUL CREMER: Open Payments
NPI 1295417863 · MOUNT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 64 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $259 |
| Novo Nordisk Inc | 9 | $183 |
| Astellas Pharma US Inc | 5 | $114 |
| ABBVIE INC. | 4 | $80 |
| Esperion Therapeutics, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Lundbeck LLC | 3 | $65 |
| Exact Sciences Corporation | 3 | $57 |
| Lilly USA, LLC | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
Products named: Veozah, ELIQUIS, REXULTI, PREVNAR 20, Wegovy, NEXLETOL, Auvelity, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
